CASL - Canadian Association for the Study of the Liver

EASL Congress 2024
2024-06-05 - 2024-06-08 | Allianz MiCo, Milan, Italy, Allianz MiCo, Milan, Italy
Welcome to EASL Congress 2024, a gathering that unites the world of hepatology, taking place from 5-8 June 2024 in Milan, Italy, as well as online.

Bringing together over 7,000 professionals, including clinicians, researchers, allied health professionals, patient representatives, and industry professionals, the EASL Congress stands out as Europe’s largest event in this domain.
Four days of congress full of interactivity and hands-on learning sessions from world-class faculty. Excellent opportunities for the liver community to present their research, network and interact face-to-face with the greatest minds in hepatology.

Canadian Viral Hepatitis Elimination Day
2024-05-09 08:00 - 17:00 UTC | Ottawa, Canada
On Thursday, May 9, 2024, the Canadian Association for the Study of the Liver will join Action Hepatitis Canada, CanHepC, CanHepB, and the Canadian Liver Foundation to mark the 3rd annual Canadian Viral Hepatitis Elimination Day in Ottawa.
#CanHepDay24 #HepCantWait
Thank you to our many members and allies who are helping amplify our call for the federal government, as well as each province and territory, to bring urgency to eliminating viral hepatitis as a public health threat in Canada by 2030.
FIVE FEDERAL ASKS
In 2016, Canada made an international commitment to eliminate viral hepatitis as a public health threat by 2030. While much of this work falls to the provinces and territories, there are five key things the federal government can do now.
1. Planning: Add targets to measure progress in eliminating viral hepatitis to the 2025-2030 STBBI Action Plan.
An updated federal STBBI Action Plan was launched in January 2024. The plan excludes targets to measure Canada’s progress and inform federally funded projects. Targets are integral to an elimination plan.
2. Testing: Update hepatitis C screening guidelines to be evidence-based, develop evidence-based screening guidelines for hepatitis B, and start offering free, voluntary STBBI testing and linkage to care for all immigrants and newcomers.
Canada’s hepatitis C screening guidelines recommend only screening people with certain risk factors, despite all evidence that risk-based screening guidelines are ineffective at identifying chronic hepatitis C infections in time to avoid advanced liver disease or death. Canada does not have national hepatitis B screening guidelines at all, resulting in many people being diagnosed at the same time they receive their liver cancer diagnosis.
3. Testing-to-Treatment Link: Engage manufacturers of point-of-care testing technologies to bring these tests to Canada.
Hepatitis C is curable and hepatitis B is treatable. It takes several appointments to proceed from initial screening to starting treatment, in part because point-of-care confirmatory testing technology used in other parts of the world is not yet available in Canada.
​
4. Prevention: Update NACI guidelines to recommend universal birth-dose hepatitis B vaccination.
Hepatitis B is vaccine-preventable. Canada is out of step with the WHO’s recommendation that even regions with low incidence of hepatitis B provide universal birth dose vaccination. Five provinces still offer the first publicly-funded doses of hepatitis B vaccine in school-based programs for ages 9-12, which have a vaccination rate of ~70%, missing the 90% WHO target.
5. Data: Fund and increase efforts to collect updated hepatitis B and C prevalence estimates and population-specific cascades of care for all Canadian provinces and territories.
In order to measure our progress in viral hepatitis elimination, we need reliable, fulsome data about how many people are affected.

Social Media Graphics for Sharing

These graphics can be shared on social media with your own message and the hashtags #HepCantWait and #CanHepDay24.

Click on the image to save it

Click on the image to save it

Innovations in SLD Think-Tank 2024
2024-05-03 - 2024-05-04
This 2-day program will provide an interactive platform for endocrinologists, gastroenterologist hepatologists, primary care physicians, and associated health care professionals (PAs, nurses) working in the field of SLD. Outmost goal is to allow knowledge exchange on MASLD beyond the hepatology arena and among all levels of expertise.

The new format will employ the Wilton Park style in which we intend to have panel discussions around hot topics in order to generate ideas and provide insights and recommendations:

Bridging the Diagnostics Gap
Prevention is the ‘Cure’ Hidden in Plain Sight
The Future of Treatments Now
Making Ready Our World Unready
Targeting Investments for Social and Economic Returns
the Role of Social Media in MASLD Education
Open Science Session on MASLD

Each of the topics will be introduced by a short lecture highlighting the issue and kick-starting the discussion. After a focused discussion among the panel members, the discussion is opened to the audience ensuring an informal and interactive setting to discuss audience-proposed topics.
Register for SLD Think-Tank 2024
In addition, the SLD Think-Tank will accept abstract submissions and look forward to inviting the key contributors to take part in the relevant panel discussions.
Abstract Deadline: Friday, 1 March 2024 at 23:59 CET
Abstract Submission Link: https://virology.eventsair.com/sld2024/abstracts

World Liver Awareness Day Webinar
2024-04-19 10:00 - 11:30 (Europe/Helsinki)
SOLDA is proud to present World Liver Awareness Day Webinar, a 90-minute webinar focusing on challenges and solutions for liver disease in Africa.
The 90-minute program takes place on World Liver Day – 19 April 2024 – and showcases presentations from leading experts from the five African regions. The scientific program focuses on regionally prevalent and emerging liver diseases and special emphasis will be placed on ensuring the voices of those with lived experiences will be heard.

10:00 AM CAT / SAST
WHA – Patient Advocacy Group | The “Lost Voice” of the Patient Community
Danjuma K. Adda, MPH, FIMS, Dip-IMS, World Hepatitis Alliance (WHA), Nigeria

10:10 AM CAT / SAST
Eastern Africa | Viral Hepatitis (Delivery of Care Models)
Mercy Nyakowa, MD National AIDS and STI Control Program (NASCOP), Ministry of Health, Kenya
Hailemichael Desalegn Mekonnen, MD, PhD, St. Paul’s Hospital Millennium Medical College, Ethiopia
Ponsiano Ocama, MBChB, MMed, PhD, FCP(ECSA), Makerere University College of Health Sciences, Uganda
10:20 AM CAT
Western Africa | Role of Prolifica in Viral Hepatitis (Implementation & Research)
Gibril Ndow, MD, PhD, Unit The Gambia at LSHTM, The Gambia
Alice Nanelin Guingané, MD, MPH, Bogodogo University Hospital Center / University of Montpellier, Burkina Faso / France
10:30 AM CAT / SAST
Central Africa | Vertical Transmission
Christian Tzeuton, MD, Douala Medical School / Société Camerounaise de Gastro-Entérologie, Cameroon
10:40 AM CAT / SAST
Southern Africa | Alcohol & Toxins
Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD, University of Cape Town, South Africa
Mark Sonderup, B Pharm, MBChB, FCP(SA), MMed, University of Cape Town, South Africa
Seadimo Gasennelwe-Gabakgore, MD, MPH, Ministry of Health and Wellness, Botswana
10:50 AM CAT / SAST
Northern Africa | HCC
Manal Hamdy El-Sayed, MD, PhD, Ain Shams University, Egypt
Ashraf Omar, MD, MSc, Cairo University, Egypt
Nabil Debzi, MD, Algerian Society of Hepatogastroenterology and Endoscopy / Mustapha Hospital Algiers, Algeria
11:00 AM CAT / SAST
Q&A
11:30 AM CAT / SAST
Closure of Webinar

Obesity Update Congress
2024-04-11 | InterContinental Toronto Centre, 225 Front Street West, Toronto, Ontario, M5V 2X3, Canada
The inaugural Obesity Update (OU) congress is taking place on Thursday, April 11, 2024, at the InterContinental Toronto Centre. Additional information about the congress can be found on the website at www.obesityupdate.ca.

Online Opioid Self-Assessment Program (SAP)
2024-03-15 - 2024-04-30
Improve your opioid prescribing skills with the Online Opioid SAP accredited by both the Royal College of Physicians and Surgeons of Canada and the College of Family Physicians of Canada. Engage with the latest Canadian Opioid Guideline through interactive case studies and personalized feedback. Funded by Health Canada and CGPA, this not-for-profit program is your gateway to evidence-based opioid management.
This course is accredited as Section 3 for specialists (3 credits/hour) and Mainpro+ for Family Physicians (1 credit/hour).
The Online Opioid SAP is easily accessible, highly interactive, and it uses assessment as a technique for knowledge exchange and guideline implementation. To facilitate active learning, various styles are employed, including videos, case presentations, and an assortment of question types to keep you engaged and apply it in practice.
Secure, confidential, and always seeking your feedback to improve healthcare practices. Join the Online Opioid SAP at https://opioidassessment.ca/ and elevate your clinical expertise today.

Quality of Lift Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension
2024-02-21 12:00 (America/Toronto) | Online
The Canadian Society of Palliative Care Physicians has partnered with the Pulmonary Hypertension Association of Canada to offer the webinar, Quality of Lift Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension, on Feb 21st.
Palliative Care ECHO Project to offer targeted webinars to all physicians who treat patients with life-limiting illness. These sessions are accredited, free and open to everyone.

Quality of Life Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension
WEDNESDAY, February 21, 2024TIME: 9 AM PT / 10 AM MT / 3 PM CT / 4 PM ET / 5 PM ATL / 5:30 PM NL
Hosted by the Canadian Society of Palliative Care Physicians (CSPCP) and Pulmonary Hypertension Association of Canada (PHA Canada)
Presenters:
Dr. David Christiansen, MD FRCPC
Associate Professor and Co-Section Head, Section of Respirology,
University of Manitoba
Dr. Kirsten Wentlandt, MD, CCFP(PC), FRCPC, PhD, MHSc
W. Gifford-Jones Professor in Pain Control and Palliative Care,
Head of the Division of Palliative Care, University of Toronto
Target Audience: Physicians from across Canada
Description:Explore palliative care strategies for individuals with pulmonary hypertension (PH). We’ll delve into the disease course, prognosis, and impact on quality of life for patients with PH. Additionally, we’ll examine the opportunities and challenges in providing palliative care to individuals facing this condition, highlighting unique aspects as it relates to palliative care interventions.
In this session, we will:

review disease course, quality of life and prognosis of pulmonary hypertension (PH).
review opportunities and challenges in providing palliative care to patients with PH.
discuss unique aspects of PH as it pertains to palliative care interventions.

ECHO sessions are free to attend and open to any person with an interest in the topic; however, the subject material is designed for physician audiences.
At the beginning of this session, the speaker(s) will present a case, which will be followed by a moderated and interactive discussion among participants.
The CSPCP Palliative Care Echo Sessions is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
CFPC members may claim 1 Mainpro+ Non-certified Group Learning credit
